CareDx, Inc. Stock Prediction
AI-powered sentiment analysis and prediction trends for CDNA, updated each market day.
CDNA AI Sentiment
AI sees no strong directional signal for CareDx, Inc. stock over the next 10 market days.
Prediction date: April 10, 2026
Subscribers see precise scores, buy/sell targets, and full analytics.
About CareDx, Inc.
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically it generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.
Sector
Exchange
Market Cap
$854,800,781
Cap Tier
Employees
765
Headquarters
BRISBANE, CA
Listed Since
July 17, 2014
Website
CDNA Sentiment Trend — Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
CDNA Volatility
CareDx, Inc. has shown high price volatility over the last 5 trading days. High volatility means larger price swings — this can present both opportunity and risk for traders.
